Press Releases
GreenLight biosciences Welcomes Susan Keefe as Chief Financial Officer
MEDFORD, Mass., June 11, 2019 /PRNewswire/ -- GreenLight Biosciences, Inc., the bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, welcomes Susan Keefe as chief financial officer to lead the company's financial strategy and facilitate its growth plan.
GreenLight Biosciences Boosts Its R&D Capabilities Through Key Hires
MEDFORD, Mass., May 31, 2019 /PRNewswire/ – GreenLight Biosciences, Inc., the bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, announced several new hires to augment its plant science R&D team: David Culley, head of fungicide innovation; Brian Manley, head of field development; Laurent Mézin, head of regulatory; Ken Narva, head of entomology; Cris Oppert, crop protection scientist; and Krishna Sridharan, head of data science.
GreenLight biosciences Hires Commercial Team to Bring Targeted Biocontrol Products to MarkeT
MEDFORD, Mass., March 4, 2019 /PRNewswire/ – GreenLight Biosciences, Inc., the bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, announced the hiring of three experienced agricultural leaders as the company’s commercial team. Ron Flannagan has been named director, technical portfolio management; Joe Hanson joins as director, market development; and Catie Lee will serve as senior marketing manager.
GreenLight Biosciences Announces $50 Million Funding Round
MEDFORD, Mass., Jan. 8, 2019 /PRNewswire/ — GreenLight Biosciences, Inc., the bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, announced today a $50 Million first closing of its latest funding round. The round was led by S2G Ventures, Baird Capital and Blue I/O. Several additional top-tier investors, including Continental Grain Company, Tao Capital Partners and Alexandria Venture Investments, joined the investor syndicate. The majority of existing GreenLight investors also participated in the oversubscribed round.
GreenLight Biosciences Welcomes New Chief Commercial Officer
MEDFORD, Mass., July 24, 2018 /PRNewswire/ — GreenLight Biosciences, Inc., a biotechnology company developing RNA-based products for agricultural and pharmaceutical applications, today announced that Mick Messman has joined the Company as Chief Commercial Officer. Mr. Messman has over 20 years of global agricultural sales, marketing, business development and operations experience. Prior to joining GreenLight, he spent the last 5 years building and leading the seed applied and biologicals crop protection business at Corteva Agriscience, a division of DowDuPont.
GreenLight Biosciences Announces Series D Financing, Unveils RNA Strategy
MEDFORD, Mass., Sept. 13, 2017 /PRNewswire/ — GreenLight Biosciences, Inc. announced today the completion of its $18 million Series D round of financing led by Fall Line Capital. S2G Ventures, Lewis and Clark Ventures, and Macro Capital Investments participated in the round, along with the majority of GreenLight's existing investors, including Kodiak Venture Partners, MLSCF, Syngenta Ventures and others. GreenLight is harnessing its Cell-Free Bioprocessing® platform to develop a portfolio of RNA-based products for use in agriculture.
GreenLight Biosciences to Present at the BIO World Congress on Industrial Biotechnology
BOSTON, July 18, 2017 /PRNewswire/ — GreenLight Biosciences, Inc., a biotechnology company producing novel RNA-based products for agricultural, healthcare and other applications, today announced that management will present at the BIO World Congress on Industrial Biotechnology at the Palais des Congres in Montreal, Canada. The presentation entitled "A novel platform for development of double-stranded RNA agricultural products" will be delivered by Dr. Andrey J. Zarur, Chairman and CEO of GreenLight, on Wednesday July 26th at 10:30 a.m. ET.